Outcomes of Critically Ill Patients With Severe Acute Kidney Injury Requiring Renal Replacement Therapy
PROVEER
1 other identifier
observational
245
1 country
1
Brief Summary
This study assess the vital status, renal function and renal recovery of patients admitted to intensive care unit and requiring renal replacement therapy for acute kidney failure. Patient follow up is up to 3 years after ICU admission when possible.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2014
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2015
CompletedFirst Submitted
Initial submission to the registry
August 19, 2016
CompletedFirst Posted
Study publicly available on registry
September 13, 2016
CompletedSeptember 13, 2016
September 1, 2016
6 months
August 19, 2016
September 7, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
one-year mortality
vital status
year 1
Secondary Outcomes (2)
hospital mortality
year 1
one year renal function
Year one
Study Arms (1)
critically ill patients
critically ill patients with acute kidney failure requiring renal replacement therapy
Eligibility Criteria
Adults hospitalised in intensive care and who developped acute renal failure requiring renal replacement therapy
You may qualify if:
- Adults admitted to the intensive care
- Acute kidney failure requiring renal replacement therapy
You may not qualify if:
- Patients suffering end stage renal failure requiring chronic renal replacement therapy
- Patients under 18 years
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHRU de Brest
Brest, 29609, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Aubron Cécile
CHRU de Brest
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 19, 2016
First Posted
September 13, 2016
Study Start
November 1, 2014
Primary Completion
May 1, 2015
Study Completion
May 1, 2015
Last Updated
September 13, 2016
Record last verified: 2016-09